Canabidiol, E, Método Para Tratamento De Epilepsia Resistente A Tratamento.

  • Published: Aug 22, 2017
  • Earliest Priority: Jun 17 2014
  • Family: 37
  • Cited Works: 0
  • Cited by: 0
  • Cites: 0
  • Additional Info:
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).


Claims

Information currently unavailable.

CPC Classifications
IPC Classifications
Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Aug 22, 2017
  • Application: Jun 17, 2015
    BR BR 112016029506 A
  • Priority: Jun 17, 2015
    GB GB 2015051775 W
  • Priority: Apr 17, 2015
    GB GB 201506550 A
  • Priority: Jun 17, 2014
    GB GB 201410771 A

Sign in to the Lens

Feedback